Related Experiment Video

Updated: Aug 15, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

SUMOylation and PPARgamma: wrestling with inflammatory signaling

Noam Zelcer1, Peter Tontonoz

  • 1Howard Hughes Medical Institute, Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, California 90055, USA.

Cell Metabolism
|November 8, 2005
PubMed

Insights

Peroxisome proliferator-activated receptor gamma (PPARgamma) inhibits inflammatory gene expression via a novel SUMOylation mechanism. This process recruits PPARgamma to inflammatory gene promoters, blocking corepressor complex removal and halting transcription.

Area of Science:

  • Molecular Biology
  • Immunology
  • Gene Regulation

Background:

  • The precise molecular mechanisms by which PPARgamma (Peroxisome proliferator-activated receptor gamma) suppresses inflammatory gene expression in macrophages remain incompletely elucidated.
  • Understanding these pathways is crucial for developing targeted anti-inflammatory therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms of PPARgamma-mediated trans-repression of inflammatory gene expression.
  • To present a novel model for how PPARgamma regulates inflammatory gene transcription.

Main Methods:

  • The study employed molecular biology techniques to investigate the interaction between PPARgamma, SUMOylation, and inflammatory gene promoters.
  • Analysis focused on the recruitment of PPARgamma to gene promoters and its effect on corepressor complex dynamics.

Main Results:

  • Ligand-dependent SUMOylation of PPARgamma was identified as a key regulatory event.
  • SUMOylated PPARgamma is recruited to the promoters of inflammatory genes.
  • This recruitment inhibits transcription by impeding the clearance of corepressor complexes.

Conclusions:

  • A new model for PPARgamma-mediated trans-repression has been proposed, involving ligand-dependent SUMOylation.
  • This mechanism highlights the critical role of SUMOylation in regulating inflammatory responses at the transcriptional level.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...